The impact of the presence of youngsters on grownup smoking behaviour: empirical proof primarily based on China household panel research
Background: Regardless of various research linking household and marriage components with well being behaviour, the consequences of youngsters on the well being behaviour of oldsters are nonetheless understudied. This research explored the affiliation between the presence of youngsters and adults’ smoking behaviours.
Strategies: This research used panel information from the China Household Panel Research 2010 and 2012, and the info set included 23,157 households and 45,513 adults. Logistic regression was carried out to analyse the affiliation of the presence of youngsters on adults’ smoking behaviours. Subgroup regression was used to look at heterogeneous results.
Outcomes: Full pattern regressions confirmed that the variety of youngsters was considerably inversely related to smoking behaviour (OR = 0.93; 95% 0.90-0.96). Additional subsample regression finds that such impact is barely vital among the many high-education group (OR = 0.92; 95% 0.87-0.97), high-skill staff (OR = 0.89; 95% 0.80-0.99) and {couples} who had an age hole better than 2 years (OR = 0.91; 95% 0.88-0.95).
Conclusions: Our findings verify the existence of the upward intergenerational impact of the presence of youngsters on adults’ smoking behaviour in China. Nonetheless, such results will not be equal throughout all demographic traits. Future analysis may discover different elements of the upward mechanism and potential pathways for a stronger impact. In resource-poor areas, focusing on cessation actions at those that have youngsters at an early age could also be an efficient technique.

Core Panel Multi-Tumor control slides |
|||
TS900 | Innovex | Set of 5 | 218 EUR |
Core Panel Multi-Tumor control slides |
|||
TS900-25 | Innovex | Set of 25 | 485 EUR |
Breast Panel Multi-Tumor control slides |
|||
TS901 | Innovex | Set of 5 | 218 EUR |
Breast Panel Multi-Tumor control slides |
|||
TS901-25 | Innovex | Set of 25 | 485 EUR |
Porcine Swine FLU virus A (FLU A) ELISA Kit |
|||
QY-E40037 | Qayee Biotechnology | 96T | 400 EUR |
Ivd/ Rat Ivd ELISA Kit |
|||
ELI-39421r | Lifescience Market | 96 Tests | 886 EUR |
Mouse FLU ELISA Kit |
|||
EMF0241 | Abclonal | 96Tests | 521 EUR |
Porcine FLU ELISA Kit |
|||
EPF0241 | Abclonal | 96Tests | 521 EUR |
Rat FLU ELISA Kit |
|||
ERF0241 | Abclonal | 96Tests | 521 EUR |
Rabbit FLU ELISA Kit |
|||
ERTF0241 | Abclonal | 96Tests | 521 EUR |
Anserine FLU ELISA Kit |
|||
EAF0241 | Abclonal | 96Tests | 521 EUR |
Goat FLU ELISA Kit |
|||
EGTF0241 | Abclonal | 96Tests | 521 EUR |
Canine FLU ELISA Kit |
|||
ECF0241 | Abclonal | 96Tests | 521 EUR |
Human FLU ELISA Kit |
|||
EHF0241 | Abclonal | 96Tests | 521 EUR |
Bovine FLU ELISA Kit |
|||
EBF0241 | Abclonal | 96Tests | 521 EUR |
IVD siRNA |
|||
20-abx920988 | Abbexa |
|
|
IVD siRNA |
|||
20-abx920989 | Abbexa |
|
|
IVD antibody |
|||
22140-100ul | SAB | 100ul | 390 EUR |
IVD siRNA |
|||
20-abx902738 | Abbexa |
|
|
IVD Antibody |
|||
1-CSB-PA011921GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against IVD. Recognizes IVD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC |
|||
IVD Antibody |
|||
1-CSB-PA011921LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against IVD. Recognizes IVD from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:500-1:1000 |
|||
IVD Antibody |
|||
DF12284 | Affbiotech | 200ul | 304 EUR |
Description: IVD antibody detects endogenous levels of IVD. |
|||
anti-IVD |
|||
YF-PA12811 | Abfrontier | 50 ug | 363 EUR |
Description: Mouse polyclonal to IVD |
|||
anti-IVD |
|||
YF-PA12812 | Abfrontier | 100 ug | 403 EUR |
Description: Rabbit polyclonal to IVD |
|||
IVD antibody |
|||
10R-4491 | Fitzgerald | 100 ul | 691 EUR |
Description: Mouse monoclonal IVD antibody |
|||
IVD antibody |
|||
70R-18039 | Fitzgerald | 50 ul | 435 EUR |
Description: Rabbit polyclonal IVD antibody |
|||
IVD antibody |
|||
70R-13603 | Fitzgerald | 100 ul | 457 EUR |
Description: Affinity purified Rabbit polyclonal IVD antibody |
|||
Bordetella bronchiseptica proteins (inactivated vaccine for dog) for ELISA |
|||
BBV15-N-100 | Alpha Diagnostics | 100 ug | 286 EUR |
FLU-A DOT-ELISA Kit |
|||
DEIA436 | Creative Diagnostics | 6T/30T | 580 EUR |
Description: This kit is an in vitro immunoassay test (Dot-ELISA) for the direct, rapid and qualitative detection of nucleoprotein (NP) antigen of Influenza A Virus in human nasopharyngeal aspirates, swabs, nasal wash, chicken embryo whole virus inoculation or viral lysates, etc. It is intended for clinical identification influenza type-A viruses. |
|||
Guinea Pig FLU ELISA Kit |
|||
EGF0241 | Abclonal | 96Tests | 521 EUR |
Human FLU-H5 ELISA Kit |
|||
201-12-2128 | SunredBio | 96 tests | 440 EUR |
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human FLU-H5 ELISA Kit |
|||
QY-E04880 | Qayee Biotechnology | 96T | 361 EUR |
IVD Rabbit pAb |
|||
A15281-100ul | Abclonal | 100 ul | 308 EUR |
IVD Rabbit pAb |
|||
A15281-200ul | Abclonal | 200 ul | 459 EUR |
IVD Rabbit pAb |
|||
A15281-20ul | Abclonal | 20 ul | 183 EUR |
IVD Rabbit pAb |
|||
A15281-50ul | Abclonal | 50 ul | 223 EUR |
Human IVD Antibody |
|||
33170-05111 | AssayPro | 150 ug | 261 EUR |
IVD Polyclonal Antibody |
|||
28898-100ul | SAB | 100ul | 252 EUR |
IVD Polyclonal Antibody |
|||
28898-50ul | SAB | 50ul | 187 EUR |
anti- IVD antibody |
|||
FNab04426 | FN Test | 100µg | 505.25 EUR |
Description: Antibody raised against IVD |
|||
anti- IVD antibody |
|||
FNab04427 | FN Test | 100µg | 585 EUR |
Description: Antibody raised against IVD |
|||
Anti-IVD antibody |
|||
STJ117476 | St John's Laboratory | 100 µl | 277 EUR |
Description: Isovaleryl-CoA dehydrogenase (IVD) is a mitochondrial matrix enzyme that catalyzes the third step in leucine catabolism. The genetic deficiency of IVD results in an accumulation of isovaleric acid, which is toxic to the central nervous system and leads to isovaleric acidemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
IVD cloning plasmid |
|||
CSB-CL011921HU-10ug | Cusabio | 10ug | 465 EUR |
Description: A cloning plasmid for the IVD gene. |
|||
IVD Blocking Peptide |
|||
DF12284-BP | Affbiotech | 1mg | 195 EUR |
IVD, Human Recombinant |
|||
P1577-100 | Biovision | 100 µg | 510 EUR |
IVD, Human Recombinant |
|||
P1577-20 | Biovision | 20 µg | 156 EUR |
Anti-IVD antibody |
|||
PAab04426 | Lifescience Market | 100 ug | 355 EUR |
Saponin Vaccine Adjuvant |
|||
VAdv-Ly0009 | Creative Biolabs | 1 g | 1095 EUR |
Description: Saponin Vaccine Adjuvant, plant-based vaccine adjuvant. |
|||
Recombinant flagellin FlicC vaccine adjuvant (TLR5 agonist); vaccine adjuvant |
|||
AV-7010-50 | Alpha Diagnostics | 50 ug | 895 EUR |
Avian Flu (H5N1) Protein Detection Set |
|||
PSI-1808 | ProSci | 1 Set | 737 EUR |
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the neuraminidase protein also contributes to the high virulence of the H5N1 virus. H5N1 hemagglutinin interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.;;For images please see PDF data sheet |
|||
ELISA kit for Human PLA2G4D (Phospholipase A2, Group IVD) |
|||
ELK6188 | ELK Biotech | 1 plate of 96 wells | 432 EUR |
Description: A sandwich ELISA kit for detection of Phospholipase A2, Group IVD from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Goat IgG (-ve control for flow cytometry) (isotype control) |
|||
20011-100 | Alpha Diagnostics | 100 test | 103 EUR |
BSA Control for Age-BSA |
|||
2221-BSA | Biovision | 175 EUR | |
BSA Control for AGE-BSA |
|||
35R-AA007 | Fitzgerald | 10 mg | 224 EUR |
Description: BSA Control for AGE protein (BSA modified), Cat No. 30R-AA007 |
|||
Mouse IVD shRNA Plasmid |
|||
20-abx974716 | Abbexa |
|
|
Rat IVD shRNA Plasmid |
|||
20-abx984521 | Abbexa |
|
|
Human IVD shRNA Plasmid |
|||
20-abx952499 | Abbexa |
|
|
IVD Antibody, HRP conjugated |
|||
1-CSB-PA011921LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against IVD. Recognizes IVD from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
IVD Antibody, FITC conjugated |
|||
1-CSB-PA011921LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against IVD. Recognizes IVD from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
IVD Antibody, Biotin conjugated |
|||
1-CSB-PA011921LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against IVD. Recognizes IVD from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
IVD Polyclonal Conjugated Antibody |
|||
C28898 | SAB | 100ul | 397 EUR |
Mouse Ivd ELISA KIT |
|||
ELI-43520m | Lifescience Market | 96 Tests | 865 EUR |
Human IVD ELISA KIT |
|||
ELI-12848h | Lifescience Market | 96 Tests | 824 EUR |
Bovine IVD ELISA KIT |
|||
ELI-13527b | Lifescience Market | 96 Tests | 928 EUR |
IVD ELISA KIT|Human |
|||
EF010406 | Lifescience Market | 96 Tests | 689 EUR |
IVD Recombinant Protein (Rat) |
|||
RP206471 | ABM | 100 ug | Ask for price |
IVD Recombinant Protein (Human) |
|||
RP016447 | ABM | 100 ug | Ask for price |
IVD Recombinant Protein (Mouse) |
|||
RP144596 | ABM | 100 ug | Ask for price |
IVD protein (His tag) |
|||
80R-1262 | Fitzgerald | 100 ug | 268 EUR |
Description: Purified recombinant Human IVD protein |
|||
Calcium phosphate vaccine adjuvant |
|||
AV-1020-100 | Alpha Diagnostics | 100 ml | 219 EUR |
Peanut Oil vaccine adjuvant |
|||
AV-5010-50 | Alpha Diagnostics | 50 ml | 225 EUR |
Mineral Oil vaccine adjuvant |
|||
AV-5020-50 | Alpha Diagnostics | 50 ml | 225 EUR |
Mannide monooleate vaccine adjuvant |
|||
AV-5030-5 | Alpha Diagnostics | 5 g | 164 EUR |
HS15 Kolliphore vaccine adjuvant |
|||
AV-6010-100 | Alpha Diagnostics | 100 g | 286 EUR |
Pam2CSK4 vaccine adjuvant, unlabeled |
|||
AV-9020-1 | Alpha Diagnostics | 1 mg | 408 EUR |
Pam3CSK4 vaccine adjuvant, unlabeled |
|||
AV-9025-1 | Alpha Diagnostics | 1 mg | 286 EUR |
Mouse Monoclonal Anti-Gardasil vaccine L1s (Human Papilloma Virus/HPV6+11+16+18 late proteins) antiserum control for ELISA |
|||
HPV618L13-S | Alpha Diagnostics | 1 ml | 469 EUR |
Human Influenza viruses IgG(FLU)ELISA Kit |
|||
GA-E1783HM-48T | GenAsia Biotech | 48T | 289 EUR |
Human Influenza viruses IgG(FLU)ELISA Kit |
|||
GA-E1783HM-96T | GenAsia Biotech | 96T | 466 EUR |
Human Influenza viruses IgG,FLU ELISA Kit |
|||
201-12-1767 | SunredBio | 96 tests | 440 EUR |
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Pig Swine Influenza Virus (FLU) ELISA Kit |
|||
abx157184-96tests | Abbexa | 96 tests | 668 EUR |
Human Influenza viruses IgG(FLU)ELISA Kit |
|||
QY-E02255 | Qayee Biotechnology | 96T | 361 EUR |
Rabbit Anti-West Nile Virus vaccine (WNV, Recombitek/DNA vaccine) antiserum |
|||
WNV13-S | Alpha Diagnostics | 100 ul | 457 EUR |
Frozen Tissue Section Panel - Mouse Whole Brain Segmentation Panel |
|||
T6334035 | Biochain | 5 slides | 931 EUR |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
|||
Paraffin Tissue Section Panel - Mouse Whole Brain Segmentation Panel |
|||
T8334035 | Biochain | 5 slides | 556 EUR |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
|||
SLLK, Control Peptide for TSP1 Inhibitor |
|||
HY-P0301 | MedChemExpress | 1mg | 133 EUR |
Control for ER, 4 cases (1.5mm) |
|||
ERC081 | Pantomics | 1 | 85 EUR |
Description: IHC control array containing 4 breast cancer cases of strong, moderate, weak/nil estrogen receptor (ER) expressers in duplicates |
|||
Control for HER2, 4 cases (1.5mm) |
|||
HRC081 | Pantomics | 1 | 85 EUR |
Description: IHC control array containing 4 breast cancer cases of strong, moderate, low and negative HER2 breast cancer expressers in duplicates |
|||
Control for PR, 3 cases (1.5mm) |
|||
PRC061 | Pantomics | 1 | 85 EUR |
Description: IHC control array containing 3 breast cancer cases of strong, moderate, low/negative progesterone receptor (PR) expressers in duplicates |
|||
Control for Ckit, 6 samples (1.5mm) |
|||
CKIT061 | Pantomics | 1 | 85 EUR |
Description: Gastrointestinal stroma tumors, 6 cores, 3 cases in duplicates showing strong, moderate and no expression of cKit molecule. |
|||
Control for DOG1, 3 cases (1.5mm) |
|||
DOG1061 | Pantomics | 1 | 85 EUR |
Description: IHC control array containing 3 GIST cases of strong, moderate, weak/nil DOG1 expressers in duplicates |
|||
PAS/Glycogen, For Digestion (Control Slides) |
|||
TCS0024-100 | ScyTek Laboratories | 100 Slides | 706 EUR |
PAS/Glycogen, For Digestion (Control Slides) |
|||
TCS0024-25 | ScyTek Laboratories | 25 Slides | 232 EUR |
PAS/Glycogen, For Digestion (Control Slides) |
|||
TCS0024-5 | ScyTek Laboratories | 5 Slides | 98 EUR |
Thiostatin Rat protein, control for western |
|||
TSTN11-C | Alpha Diagnostics | 100 ul | 286 EUR |
Control/Blocking peptide for Human WNT5a |
|||
WNT511-P | Alpha Diagnostics | 100 ug | 164 EUR |
Human IVD Antibody (Biotin Conjugate) |
|||
33170-05121 | AssayPro | 150 ug | 369 EUR |
Ivd ORF Vector (Rat) (pORF) |
|||
ORF068825 | ABM | 1.0 ug DNA | 506 EUR |
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring a number of NNRTI resistance mutations
Targets: Doravirine is a not too long ago licensed HIV-1 NNRTI with improved efficacy, pharmacokinetics and security profile in contrast with efavirenz and restricted cross-resistance with rilpivirine and etravirine. On this in vitro research, cross-resistance to doravirine was analysed in a consultant panel of NNRTI-resistant clones.
Strategies: In vitro phenotypic susceptibility to doravirine was assessed in 10 clinically derived infectious clones with intermediate- to high-level resistance to rilpivirine, etravirine, efavirenz and nevirapine, and in NL4-Three site-directed mutants harbouring Ok103N, Y181C, M230L or Ok103N/Y181C NNRTI mutations
Outcomes: Though not one of the infectious clones harboured any of the most important doravirine resistance-associated mutations (RAMs) included within the IAS-USA reference listing, doravirine fold change (FC) values have been corresponding to or larger than these calculated for different NNRTIs, significantly etravirine and rilpivirine.
As anticipated, single NNRTI mutations Ok103N and Y181C didn’t impair doravirine susceptibility (FC 1.Four and 1.8, respectively), whereas decreased exercise was noticed with the only M230L or double Ok103N/Y181C mutations (FC 7.6 and 4.9, respectively). Median FC values elevated considerably with growing numbers of NNRTI RAMs (P = 0.005) and have been >10 in 4/Four and 1/Four clones harbouring 4 and three NNRTI RAMs, respectively. FC values correlated nicely with predicted susceptibility as inferred by Stanford HIV Drug Resistance Database (HIVdb) and ANRS algorithms (each P < 0.001).
Conclusions: Substantial cross-resistance to doravirine was detected in NNRTI-resistant viruses harbouring complicated mutational patterns, even within the absence of main IAS-USA doravirine RAMs. Due to this fact, primarily based on the straightforward IAS-USA reference listing, doravirine resistance could also be underestimated in viruses harbouring a number of NNRTI mutations.
Affiliation between modifications in financial exercise and catastrophic well being expenditure: findings from the Korea Well being Panel Survey, 2014-2016
Background: The speed of catastrophic well being expenditure (CHE) continues to rise in South Korea. This research examined the affiliation between modifications in financial exercise and CHE experiences in South Korea.
Strategies: This research analyzed the Korea Well being Panel Survey information utilizing a logistic regression evaluation to check the affiliation between modifications in financial exercise in 2014-2015 and the members’ CHE experiences in 2015. The research included a complete of 12,454 people over the age of 19. The subgroup analyses have been organized by intercourse, age, health-related variables, and family degree variables, and the explanations for leaving financial exercise.
Outcomes: Those that stop financial actions have been extra more likely to expertise CHE than those that continued to have interaction in financial actions (OR [odds ratio] = 2.10; 95% CI [confidence interval]: 1.31-3.36). The subgroup evaluation outcomes, in accordance with health-related variables, confirmed that there’s a tendency to the next Charlson comorbidity index, the next OR, and, in teams that stop their financial actions, folks with disabilities have been extra more likely to expertise CHE than folks with out disabilities (OR = 5.63; 95% CI 1.71-18.59, OR = 1.82; 95% CI 1.08-3.08, respectively).
One other subgroup evaluation discovered that if the explanation for not taking part in financial exercise was a health-related concern, the participant was extra more likely to expertise CHE (energetic → inactive: OR = 2.40; 95% CI 0.61-9.43, inactive → inactive OR = 1.65; 95% CI 1.01-2.68).
Conclusions: These people who turned unemployed have been extra more likely to expertise CHE, particularly if well being issues precipitated the job loss. Due to this fact, efforts are wanted to develop protection for these individuals who undergo from excessive medical bills.
SeroDetect HIV-Ab Verification Panel (5 X 1.5 mL) |
|||
KZMC006 | Zeptometrix | 5 X 1.5 mL | 278.8 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
SeroDetect Anti-HBs Verification Panel (6 X 1.5 mL) |
|||
KZMC008 | Zeptometrix | 6 X 1.5 mL | 278.8 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
SeroDetect Anti-HBcore Verification Panel (5 X 1.5 mL) |
|||
KZMC009 | Zeptometrix | 5 X 1.5 mL | 278.8 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
SeroDetect Anti-HCV Verification Panel (5 X 1.5 mL) |
|||
KZMC010 | Zeptometrix | 5 X 1.5 mL | 278.8 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
SeroDetect HTLV Ab Verification Panel (5 X 1.5 mL) |
|||
KZMC011 | Zeptometrix | 5 X 1.5 mL | 278.8 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
SeroDetect Dengue Fever Verification Panel (10 X 0.5 mL) |
|||
KZMC028 | Zeptometrix | 10 X 0.5 mL | 272.56 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
SeroDetect HIV-Ab Range Verification Panel (10 X 1.5 mL) |
|||
KZMC024 | Zeptometrix | 10 X 1.5 mL | 278.8 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
SeroDetect West Nile Virus Verification Panel (10 X 0.5 mL) |
|||
KZMC027 | Zeptometrix | 10 X 0.5 mL | 278.8 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
Core Panel Multi-Tumor control slides |
|||
TS900 | Innovex | Set of 5 | 218 EUR |
Core Panel Multi-Tumor control slides |
|||
TS900-25 | Innovex | Set of 25 | 485 EUR |
Breast Panel Multi-Tumor control slides |
|||
TS901 | Innovex | Set of 5 | 218 EUR |
Breast Panel Multi-Tumor control slides |
|||
TS901-25 | Innovex | Set of 25 | 485 EUR |
Recombinant purified Hepatitis Surface Antigen (HBsAg) protein control for WB |
|||
HBA11-C | Alpha Diagnostics | 100 ul | 286 EUR |
SeroDetect HCV-Ab Mixed Titer Verification Panel I (15 X 0.25 mL) |
|||
KZMC022 | Zeptometrix | 15 X 0.25 mL | 266.32 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
SeroDetect HIV-1/ HIV-2 Ag/Ab Combo Verification Panel (5 X 1.25mL) |
|||
KZMC030 | Zeptometrix | 5 X 1.25mL | 313.12 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
Ivd/ Rat Ivd ELISA Kit |
|||
ELI-39421r | Lifescience Market | 96 Tests | 886 EUR |
IVD siRNA |
|||
20-abx920988 | Abbexa |
|
|
IVD siRNA |
|||
20-abx920989 | Abbexa |
|
|
IVD antibody |
|||
22140-100ul | SAB | 100ul | 390 EUR |
IVD siRNA |
|||
20-abx902738 | Abbexa |
|
|
IVD Antibody |
|||
1-CSB-PA011921GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against IVD. Recognizes IVD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC |
|||
IVD Antibody |
|||
1-CSB-PA011921LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against IVD. Recognizes IVD from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:500-1:1000 |
|||
IVD Antibody |
|||
DF12284 | Affbiotech | 200ul | 304 EUR |
Description: IVD antibody detects endogenous levels of IVD. |
|||
anti-IVD |
|||
YF-PA12811 | Abfrontier | 50 ug | 363 EUR |
Description: Mouse polyclonal to IVD |
|||
anti-IVD |
|||
YF-PA12812 | Abfrontier | 100 ug | 403 EUR |
Description: Rabbit polyclonal to IVD |
|||
IVD antibody |
|||
10R-4491 | Fitzgerald | 100 ul | 691 EUR |
Description: Mouse monoclonal IVD antibody |
|||
IVD antibody |
|||
70R-18039 | Fitzgerald | 50 ul | 435 EUR |
Description: Rabbit polyclonal IVD antibody |
|||
IVD antibody |
|||
70R-13603 | Fitzgerald | 100 ul | 457 EUR |
Description: Affinity purified Rabbit polyclonal IVD antibody |
|||
HRP-HBsAg |
|||
C050101-10ml | Unibiotest | 10ml | 2635 EUR |
HRP-HBsAg |
|||
C050101-1ml | Unibiotest | 1ml | 438 EUR |
HBsAg Protein |
|||
abx060551-1mg | Abbexa | 1 mg | 1553 EUR |
HBsAg Protein |
|||
abx060552-1mg | Abbexa | 1 mg | 1010 EUR |
HBsAg Protein |
|||
abx060560-1mg | Abbexa | 1 mg | 1121 EUR |
HBsAg Protein |
|||
abx060562-1mg | Abbexa | 1 mg | 1567 EUR |
HbsAg antibody |
|||
20R-2830 | Fitzgerald | 1 ml | 565 EUR |
Description: Goat polyclonal HbsAg antibody |
|||
HBsAg antibody |
|||
10-1323 | Fitzgerald | 1 mg | 136 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-1324 | Fitzgerald | 1 mg | 136 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-3128 | Fitzgerald | 1 mg | 230 EUR |
Description: Mouse Monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-3130 | Fitzgerald | 1 mg | 230 EUR |
Description: Mouse Monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-3131 | Fitzgerald | 1 mg | 230 EUR |
Description: Mouse Monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-7857 | Fitzgerald | 1 mg | 314 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-7858 | Fitzgerald | 1 mg | 306 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05A | Fitzgerald | 1 mg | 220 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05B | Fitzgerald | 1 mg | 220 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05C | Fitzgerald | 1 mg | 592 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05D | Fitzgerald | 1 mg | 220 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05F | Fitzgerald | 1 mg | 220 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05G | Fitzgerald | 1 mg | 228 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05H | Fitzgerald | 1 mg | 228 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05J | Fitzgerald | 1 mg | 192 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05N | Fitzgerald | 1 mg | 220 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H114C | Fitzgerald | 1 mg | 336 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H114D | Fitzgerald | 1 mg | 325 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10C-CR1279M1 | Fitzgerald | 100 ug | 281 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
70-1088 | Fitzgerald | 1 mg | 219 EUR |
Description: Goat polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
70-HH15 | Fitzgerald | 1 mg | 258 EUR |
Description: Horse polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10R-H114c | Fitzgerald | 1 mg | 489 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10R-H114d | Fitzgerald | 1 mg | 472 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
20-HR20 | Fitzgerald | 1 mg | 337 EUR |
Description: Rabbit polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
20C-CR2100G | Fitzgerald | 1 ml | 133 EUR |
Description: Goat polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
20C-CR2100GP | Fitzgerald | 1 ml | 427 EUR |
Description: Goat polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
70R-HG003 | Fitzgerald | 1 mg | 246 EUR |
Description: Goat polyclonal HBsAg antibody |
|||
Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide control/blocking peptide |
|||
HBVS12-P | Alpha Diagnostics | 100 ug | 225 EUR |
IVD Rabbit pAb |
|||
A15281-100ul | Abclonal | 100 ul | 308 EUR |
IVD Rabbit pAb |
|||
A15281-200ul | Abclonal | 200 ul | 459 EUR |
IVD Rabbit pAb |
|||
A15281-20ul | Abclonal | 20 ul | 183 EUR |
IVD Rabbit pAb |
|||
A15281-50ul | Abclonal | 50 ul | 223 EUR |
Human IVD Antibody |
|||
33170-05111 | AssayPro | 150 ug | 261 EUR |
IVD Polyclonal Antibody |
|||
28898-100ul | SAB | 100ul | 252 EUR |
IVD Polyclonal Antibody |
|||
28898-50ul | SAB | 50ul | 187 EUR |
anti- IVD antibody |
|||
FNab04426 | FN Test | 100µg | 505.25 EUR |
Description: Antibody raised against IVD |
|||
anti- IVD antibody |
|||
FNab04427 | FN Test | 100µg | 585 EUR |
Description: Antibody raised against IVD |
|||
Anti-IVD antibody |
|||
STJ117476 | St John's Laboratory | 100 µl | 277 EUR |
Description: Isovaleryl-CoA dehydrogenase (IVD) is a mitochondrial matrix enzyme that catalyzes the third step in leucine catabolism. The genetic deficiency of IVD results in an accumulation of isovaleric acid, which is toxic to the central nervous system and leads to isovaleric acidemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
IVD cloning plasmid |
|||
CSB-CL011921HU-10ug | Cusabio | 10ug | 465 EUR |
Description: A cloning plasmid for the IVD gene. |
|||
IVD Blocking Peptide |
|||
DF12284-BP | Affbiotech | 1mg | 195 EUR |
IVD, Human Recombinant |
|||
P1577-100 | Biovision | 100 µg | 510 EUR |
IVD, Human Recombinant |
|||
P1577-20 | Biovision | 20 µg | 156 EUR |
Anti-IVD antibody |
|||
PAab04426 | Lifescience Market | 100 ug | 355 EUR |
Hepatitis B Surface Antigen (HBsAg) pre-S2 (55-aa) control/blocking peptide |
|||
HBVS23-P | Alpha Diagnostics | 100 ug | 225 EUR |
Human HBsAg Protein |
|||
abx060118-1mg | Abbexa | 1 mg | 411 EUR |
HBsAg ad Protein |
|||
abx060555-100ug | Abbexa | 100 ug | 878 EUR |
HBsAg adr Protein |
|||
abx060556-05mg | Abbexa | 0.5 mg | 1567 EUR |
HBsAg adw Protein |
|||
abx060557-01mg | Abbexa | 0.1 mg | 1017 EUR |
HBsAg adw Protein |
|||
abx060558-05mg | Abbexa | 0.5 mg | 1295 EUR |
HBsAg ay Protein |
|||
abx060563-100ug | Abbexa | 100 ug | 815 EUR |
HBsAg ayw Protein |
|||
abx060565-05mg | Abbexa | 0.5 mg | 1358 EUR |
HBsAg ayw Protein |
|||
abx060566-05mg | Abbexa | 0.5 mg | 1497 EUR |
HBsAg adw Protein |
|||
abx060567-1mg | Abbexa | 1 mg | 1017 EUR |
Anti-HBsAg antibody |
|||
STJ16101373 | St John's Laboratory | 1 mg | 538 EUR |
Anti-HBsAg antibody |
|||
STJ180119 | St John's Laboratory | 0.1 ml | 212 EUR |
HBsAg antibody (biotin) |
|||
60C-CR2100GB | Fitzgerald | 1 ml | 457 EUR |
Description: Goat polyclonal HBsAg antibody (biotin) conjugated |
|||
HBsAg antibody (FITC) |
|||
60C-CR2100GF | Fitzgerald | 1 ml | 363 EUR |
Description: Goat polyclonal HBsAg antibody (FITC) conjugated |
|||
HBsAg antibody (HRP) |
|||
60C-CR2100GX | Fitzgerald | 1 ml | 451 EUR |
Description: Goat polyclonal HBsAg antibody (HRP) conjugated |
|||
HBsAg antibody (biotin) |
|||
60C-CR2100RB | Fitzgerald | 1 ml | 453 EUR |
Description: Rabbit polyclonal HBsAg antibody (biotin) conjugated |
|||
HBsAg antibody (FITC) |
|||
60C-CR2100RF | Fitzgerald | 1 ml | 385 EUR |
Description: Rabbit polyclonal HBsAg antibody (FITC) conjugated |
|||
HBsAg antibody (HRP) |
|||
60C-CR2100RX | Fitzgerald | 1 ml | 445 EUR |
Description: Rabbit polyclonal HBsAg antibody (HRP) conjugated |
|||
HBsAg antibody (biotin) |
|||
61-1066 | Fitzgerald | 1 ml | 133 EUR |
Description: Mouse monoclonal HBsAg antibody (biotin-conjugated) |
|||
ELISA kit for Human PLA2G4D (Phospholipase A2, Group IVD) |
|||
ELK6188 | ELK Biotech | 1 plate of 96 wells | 432 EUR |
Description: A sandwich ELISA kit for detection of Phospholipase A2, Group IVD from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |